Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0444
+0.0036 (8.82%)
May 9, 2025, 10:16 AM EDT

Ayala Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022
Period Ending
May '25 Dec '23 Dec '22
Market Capitalization
28-
Enterprise Value
57-
Last Close Price
0.040.67-
PS Ratio
152.07610.40-
PB Ratio
-0.08-0.32-
EV/Sales Ratio
-559.86-
Debt / Equity Ratio
-0.34-0.34-1.59
Asset Turnover
0.000.00-
Quick Ratio
0.200.200.43
Current Ratio
0.300.300.51
Return on Assets (ROA)
-181.05%-181.05%-
Earnings Yield
-2431.65%-605.81%-
Buyback Yield / Dilution
--107.90%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.